Drug Companies Seek Trademarks At Early Stage, Survey Finds

Law360, New York (February 19, 2004, 12:00 AM EST) -- Drug companies are developing trademarks for new products at an early stage in an effort to entrench a brand in the minds of physicians, a new survey has found.

The overwhelming majority of the companies surveyed develops the generic and trademark names--92% and 84% respectively--by or during Phase II of clinical trials, according to a new benchmark study by consulting firm Best Practices, LLC.

As many as 40% of companies use the trademark before using the generic name, reflecting a growing trend to entrench the trademark...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.